Back to Search
Start Over
A phase II single-arm study of the FGFR inhibitor pemigatinib in patients with metastatic colorectal cancer (mCRC) harboring FGF/FGFR alterations.
- Source :
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p139-139, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 161484614
- Full Text :
- https://doi.org/10.1200/JCO.2023.41.4_suppl.139